Catalyst Pharmaceuticals Inc.
Angelini Pharma agreed to acquire Catalyst Pharmaceuticals for $31.50 per share in cash. U.S. antitrust approval had already been received and shareholders approved the…
The Gabelli ABC Fund seeks attractive total returns across market conditions without excessive risk of capital loss. It focuses on announced corporate events and may hold significant Treasury-bill exposure while waiting for opportunities.
Angelini Pharma agreed to acquire Catalyst Pharmaceuticals for $31.50 per share in cash. U.S. antitrust approval had already been received and shareholders approved the…
Long Lake Management agreed to acquire Global Business Travel Group for $9.50 per share in cash. The transaction still required shareholder and regulatory approvals at the time…
Berkshire Hathaway agreed to acquire Taylor Morrison for $72.50 per share in cash. U.S. antitrust approval had already been received, leaving shareholder approval and closing…
Source PDFs are not republished here; only extracted ideas and quotes.